Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment
2004866 citationsClaus Cursiefen, Lu Chen et al.Journal of Clinical Investigationprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Jingtai Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingtai Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingtai Cao more than expected).
This network shows the impact of papers produced by Jingtai Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingtai Cao. The network helps show where Jingtai Cao may publish in the future.
Co-authorship network of co-authors of Jingtai Cao
This figure shows the co-authorship network connecting the top 25 collaborators of Jingtai Cao.
A scholar is included among the top collaborators of Jingtai Cao based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Jingtai Cao. Jingtai Cao is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Liu, Yang, et al.. (2020). Cas9 and AAV Vector-Based Strategies for X-linked Juvenile Retinoschisis (XLRS) Therapy. Investigative Ophthalmology & Visual Science. 61(7). 800–800.1 indexed citations
7.
Luz, Antonio N., et al.. (2020). Intravitreal Half-lives of Aflibercept and Brolucizumab in Rabbit Measured Using In Vivo Fluorophotometry. Investigative Ophthalmology & Visual Science. 61(7). 4926–4926.3 indexed citations
Liu, Yang, Jifang Tao, Joel Martin, et al.. (2018). Wild Type and Mutant Retinoschisin Subunits Co-assemble When Expressed in the Same Cells. Investigative Ophthalmology & Visual Science. 59(9). 3050–3050.1 indexed citations
11.
Iglesias, Bibiana V., et al.. (2018). Aflibercept in combination with nesvacumab (anti-Ang2) induces vascular remodeling in a rabbit model of pathological neovascularization.. Investigative Ophthalmology & Visual Science. 59(9). 1447–1447.1 indexed citations
12.
Iglesias, Bibiana V., et al.. (2017). Co-administration of an Antibody to Angiopoietin2 Extends the Duration of the Anti-Vascular Leak Activity of Aflibercept in a Model of Sustained Retinal Neovascularization (RNV). Investigative Ophthalmology & Visual Science. 58(8). 4069–4069.2 indexed citations
13.
Cheung, Eunice, Stanley J. Wiegand, Jingtai Cao, Carmelo Romano, & Ivan B. Lobov. (2016). Inhibiting Platelet Derived Growth Factor Receptor β (PDGFRβ) affects vessel morphology and growth of developing retinal vessels, and induces leucocyte infiltration in mice. Investigative Ophthalmology & Visual Science. 57(12). 4605–4605.1 indexed citations
14.
Cheung, Eunice, Angela Sun, Frank Kuhnert, et al.. (2016). An assessment of the angiogenic effects of VEGF-A and ANGPTL4 in the mouse retina.. Investigative Ophthalmology & Visual Science. 57(12). 121–121.2 indexed citations
15.
Liu, Yang, et al.. (2015). Systemic Administration of Anti-Angiopoietin-2 (Ang-2) Antibody Inhibits Matrigel Induced Choroidal Neovascularization (CNV) in Rats. Investigative Ophthalmology & Visual Science. 56(7). 2359–2359.1 indexed citations
16.
Cheung, Eunice, et al.. (2015). Effects of combined inhibition of VEGF and Ang2 using aflibercept (VEGF Trap) and anti-Ang2 antibody on the developing retinal angiogenesis in mice.. Investigative Ophthalmology & Visual Science. 56(7). 2308–2308.2 indexed citations
17.
Hu, Ying, et al.. (2014). Evaluation of complement activity in wild type, C5 knockout and humanized mice for drug discovery. Investigative Ophthalmology & Visual Science. 55(13). 1324–1324.
18.
Hu, Ying, et al.. (2013). Genetic deletion of TLR4 increases retinal ganglion cell survival after optic nerve injury. Investigative Ophthalmology & Visual Science. 54(15). 3253–3253.1 indexed citations
19.
Cursiefen, Claus, Lu Chen, David G. Jackson, et al.. (2004). VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. Journal of Clinical Investigation. 113(7). 1040–1050.866 indexed citations breakdown →
20.
Nakajima, Masami, et al.. (2001). Normalization of retinal vascular permeability in experimental diabetes with genistein.. PubMed. 42(9). 2110–4.45 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.